Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study

Objectives: To evaluate the outcome of intradetrusor onabotulinumtoxinA (Botox®; Allergan Inc., Dublin, Ireland) (IDB) injection in children and adolescents with non-neurogenic overactive bladder (OAB) refractory or resistant to treatment. Patients and Methods: In all, 91 patients underwent evaluati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arab J Urol
Hlavní autoři: El-Dakhakhny, Amr S., El-Karamany, Tarek M., El-Atrebi, Mohamed, Gharib, Tarek
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Paediatric Urology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6600069/
https://ncbi.nlm.nih.gov/pubmed/31285927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2090598X.2019.1600993
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky